pGHD is a medical condition that affects a child’s puberty and physical development. Somatropin injections are used to treat pGHD, improve growth in childhood, and prevent or improve metabolic impairments [...]
Pfizer partnered with Clarify Health for a real-world study assessing medication adherence to tafamidis among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study titled “Baseline Characteristics [...]
Life science and healthcare industry leaders met at the 2021 CNS Summit to reflect on how pharmaceutical companies can leverage analytics and real-world evidence (RWE) to advance inclusion and diversity [...]
Pfizer partnered with Clarify on an observational study on diagnostic testing patterns in transthyretin amyloid cardiomyopathy (ATTR-CM) patients. This novel study is the first of its kind for ATTR-CM patients. [...]
From FDA regulatory approvals to commercialization strategies to value demonstrations, real-world evidence (RWE) plays a pivotal role in the product lifecycle of diagnostics, medical devices, and digital therapeutics (DTx). The [...]